<p>The present invention provides antibodies that bind human TGF-alpha and human Epiregulin and are characterized as having high affinity, selective, and strong neutralizing properties. The antibodies are useful in the treatment of diabetic nephropathy.</p>
申请公布号
WO2012138510(A1)
申请公布日期
2012.10.11
申请号
WO2012US30802
申请日期
2012.03.28
申请人
ELI LILLY AND COMPANY;BEIDLER, CATHERINE, BRAUTIGAM;HEUER, JOSEF, GEORGE;PETROVAN, RAMONA, JUDITA